Patent · US Expired

Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof

US6830924B1 · kind B1 · utility

1Cited by

1References

20Claims

0Family size

Assignees

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB
Memorial Sloan Kettering Cancer Center · US
Cornell Research Foundation, Inc. · US

Inventors

Yao-Tseng Chen · New York, US
Ali Gure · New York, US
Solam Tsang · New York, US
Elisabeth Stockert · New York, US
Elke Jager · Frankfurt am Main, DE
Alexander Knuth · Frankfurt am Main, DE
Lloyd J. Old · New York, US

Key dates

Filing date	Mar 16, 1999
Grant date	Dec 14, 2004
Priority date	—
Expiry date	Mar 16, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to newly identified cancer associated antigens, referred to as CT7, KOC-2 and KOC-3. The invention also relates to observations regarding known molecule KOC-1. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.